Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (33653)	5/18/2000 1:24:00 PM
From: Ilaine	Read Replies (1) \| Respond to of 42523

OK, but Incyte doesn't just patent gene sequences. They describe the function of the gene patented, and describe a method of treating disease. I've copied part of an abstract of one of Incyte's patents below, with the part I think is relevant in bold letters. One question, I've been reading that some gene company's patents may be challenged because the patents don't describe the "invention" in sufficient detail that others can replicate it, believe it's Incyte, do you know? >>United States Patent 6,063,767 Lal , et al. May 16, 2000 Human phospholipid binding proteins Abstract The invention provides two human phospholipid binding proteins (PLBP) and polynucleotides which identify and encode PLBP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of PLBP.<<